Spero Therapeutics, Inc.
Develops novel treatments for multi-drug resistant bacterial infections and rare diseases.
SPRO | US
Overview
Corporate Details
- ISIN(s):
- US84833T1034
- LEI:
- Country:
- United States of America
- Address:
- 675 MASSACHUSETTS AVENUE, 2139 CAMBRIDGE
- Website:
- https://sperotherapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections. The company aims to address the growing threat of antibiotic resistance by advancing a pipeline of innovative medicines. A key candidate, tebipenem HBr, is an oral antibiotic developed for complicated urinary tract infections that has successfully completed Phase 3 trials. Spero Therapeutics actively pursues strategic partnerships to maximize the global reach and impact of its therapies for patients in need.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Spero Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Spero Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Spero Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
